• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identification and clinical application of osteoclast-derived growth factors for myeloma

Research Project

Project/Area Number 15591010
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionThe University of Tokushima

Principal Investigator

ABE Masahiro  Tokushima University, Hospital, Lecturer, 医学部・歯学部附属病院, 講師 (80263812)

Co-Investigator(Kenkyū-buntansha) OZAKI Shuji  Tokushima University, Hospital, Lecturer, 医学部・歯学部附属病院, 講師 (90314872)
INOUE Daisuke  Tokushima University, Graduate School Institute of Health Biosciences, Lecturer, 大学院・ヘルスバイオサイエンス研究部, 講師 (60314853)
MATSUMOTO Toshio  Tokushima University, Graduate School Institute of Health Biosciences, Professor, 大学院・ヘルスバイオサイエンス研究部, 教授 (20157374)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2004: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2003: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsmyeloma / osteoclast / angiogenesis / osteopontin / IL-6 / 多発性骨髄腫
Research Abstract

Multiple myeloma (MM) almost exclusively develops in the bone marrow, suggesting that the bone marrow microenvironment supports MM cell growth and survival. We found that the growth and survival of MM cells are potently enhanced by osteoclasts (Ocs). The effects of OCs were only partially inhibited by an anti-human IL-6 neutralizing antibody despite the increased production of IL-6 by OCs in co-cultures with MM cells. Furthermore, prevention of a cellular contact between MM cells and OCs by membrane filters completely abolished the OC effect. Therefore, OCs may enhance MM cell growth largely through a close cell-cell interaction by elaborating unknown factor(s) other than IL-6. Similar to osteoclastogenesis, angiogenesis is enhanced in the bone marrow in patients with MM, which has drawn considerable attention as a potential therapeutic target. We also found that OCs constitutively secrete high levels of an angiogenic noncollagenous matrix protein, osteopontin (OPN), which is known to cooperatively act with VEGF in angiogenesis. Conditioned media (CM) from OCs enhanced vascular tubule formation as potently as those from MM cells. Interestingly, CM from co-cultures of both cells further enhanced it, suggesting cooperative interactions between OCs and MM cells in angiogenesis. Antibodies against OPN or VEGF each alone partially and both in combination almost completely abrogated vascular tubule formation enhanced by CM from the co-cultures. Therefore, OCs enhance angiogenesis in concert with MM cells, which is largely mediated by cooperative actions of OPN and VEGF derived from OCs and MM cells, respectively. Collectively, OCs may enhance MM progression not only directly but also through enhanced angiogenesis, thereby forming a vicious cycle between bone destruction and MM expansion.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (4 results)

All 2004

All Journal Article (4 results)

  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion.2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104・8

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma.2004

    • Author(s)
      Hashimoto T
    • Journal Title

      Br J Haematol. 125

      Pages: 38-41

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion.2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104-8

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Ability of myeloma cells to secrete macrophage inflammatory protein(MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma.2004

    • Author(s)
      Hashimoto T
    • Journal Title

      Br J Haematol. 125

      Pages: 38-41

    • Related Report
      2004 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi